[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)

Recursion Pharmaceuticals (RXRX) sees significant social media buzz around its AI-driven drug discovery platform and NVIDIA partnership, with discussions pointing to a potential short squeeze.

About Recursion Pharmaceuticals, Inc. Class A Common Stock

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is a publicly traded company focused on AI-driven drug discovery.
Recursion Pharmaceuticals, Inc. Class A Common Stock uses the ticker $RXRX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) trading volume is up XXXXX% from the previous week.
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) social dominance is up XXXXX% from the previous week.
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) sentiment is up XXXXX% from the previous week.
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) creators is up XXXXX% from the previous week.
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) engagements is up XXXXX% from the previous week.
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) mentions is up XXXXX% from the previous week.
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) posts created is up XXXXXX% from the previous week.

Price: $XXXX

Price 24-Hour Time-Series Raw Data
The current price of RXRX is influenced by positive sentiment surrounding its AI initiatives and NVIDIA collaboration, alongside potential short squeeze dynamics. While recent social posts show a mix of bullishness and caution, the overall sentiment leans positive, suggesting upward price pressure.

24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: -XXXX%

1-Year High: $XXXXX on 2025-02-19
1-Year Low: $XXXX on 2025-11-20

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is currently AltRank #608 based on combined combined social and market metrics Daily Average: XXX
X Week: XXXXX +896
X Month: XXXXX +582
X Months: XXXXX -XXX
X Year: XXXXX +899
1-Year High: XXXXX on 2025-08-19
1-Year Low: X on 2025-04-11

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -X
X Months: XX +9
X Year: XX +2
1-Year High: XX on 2025-02-14
1-Year Low: XX on 2025-02-07

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX +73%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXXX -XX%
X Year: XXXXXXXXXX +63%
1-Year High: XXXXXXX on 2025-02-16
1-Year Low: XXXXX on 2025-11-30

Engagements by network (24h): Reddit: XX TikTok: XX X: XXXXX YouTube: XX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX +44%
X Month: XXXXX -XX%
X Months: XXXXXX +39%
X Year: XXXXXX +62%
1-Year High: XXXXX on 2025-10-22
1-Year Low: XX on 2025-09-06

Mentions by network (24h): Reddit: XX TikTok: X X: XXX YouTube: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXX +12%
X Month: XXX -XX%
X Months: XXXXX +48%
X Year: XXXXX +247%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-09-07

The most influential creators that mention Recursion Pharmaceuticals, Inc. Class A Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@beaniemaxi	X	XXXXXXX	X	XXX
@cantonmeow	X	XXXXXX	X	XXX
@Biobeats99	X	XXX	X	XXX
@midascabal	X	XXXXX	X	XXX
@HoyerTrades	X	XXX	XX	XXX
@BuyTheUgly	X	XX	X	XX
@Dimas_DiBi	X	XXX	X	XX
@_BNG_Capital	X	XXXXXX	X	XX
@EBUYUKARSLAN	X	XXXXX	X	XX
@pandaquantai	XX	XXX	X	XX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +13%
X Month: XX% -X%
X Months: XX% +20%
X Year: XX% +19%
1-Year High: XXX% on 2025-09-16
1-Year Low: XX% on 2025-06-12

Most Supportive Themes:

AI-Driven Drug Discovery: (40%) Recursion Pharmaceuticals utilizes artificial intelligence to accelerate the drug discovery and development process.
NVIDIA Partnership: (30%) A strategic partnership with NVIDIA, including a significant investment, highlights the integration of advanced AI and computing power.
Potential Short Squeeze: (20%) Analysts and social media sentiment suggest a potential short squeeze due to high short interest and positive momentum.

Most Critical Themes:

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.023%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% -XXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-05
1-Year Low: XXXX% on 2025-09-06

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-05-21

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$6.30%
X Month: $XXXXXXXXXXXXX -$2.10%
X Months: $XXXXXXXXXXXXX +$20%
X Year: $XXXXXXXXXXXXX -$19%
1-Year High: $XXXXXXXXXXXXX on 2025-02-19
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top Recursion Pharmaceuticals, Inc. Class A Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$RUN $RXRX ⚠👀 Guys Don't miss the next move in a few hours 💸➡"
X Link @GlamerGlam89508 2025-12-11T19:23Z XX followers, XX engagements

"$RXRX $GTBP $ERAS $OABI November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches. Companies deploying proprietary platforms to target previously undruggable proteins are capturing premium valuations as the sector pivots toward modularity and rapid reuse of validated mechanisms creating momentum"
X Link @risenfit 2025-12-11T18:20Z 2576 followers, XXX engagements

"$MSTR added XXXX at $XXXXXX $RXRX added XXXXX at $XXXX $NVDA added XXXX at $XXXXXX $NOW added XXXX at $XXXXXX $TTD added XXXX at $XXXXX $NOW was a killer entry (it seems) the rest.blah"
X Link @BoringWins 2025-12-11T14:51Z XX followers, XXX engagements

"RXRX Stock - Recursion Pharmaceuticals Inc Stock Breaking News Today RXRX Stock"
YouTube Link @stock 2025-12-11T10:45Z 2260 followers, X engagements